Carlsmed, Inc. (CARL) Stock Grade

About Carlsmed, Inc.'s fundamentals

Carlsmed demonstrates strong revenue momentum with 85.9% year-over-year growth, indicating substantial demand for its healthcare information services offerings. However, the company is operating unprofitably with a net margin of -58.7%, meaning it is currently losing nearly 59 cents for every dollar of revenue generated. With a reported net loss in its latest annual statement and no dividend payment, Carlsmed is reinvesting resources into growth rather than returning capital to shareholders. The company's financial metrics suggest it is in an early-stage or investment phase typical of rapidly expanding healthcare technology firms.